Patents Assigned to The University of North Carolina at Chapel Hikll
  • Highly selective 5-HT(2C) receptor agonists that show anti-psychotic effects with antagonist activity at the 5-HT(2B) receptor
    Patent number: 8492591
    Abstract: Highly selective 5-HT(2C) receptor agonists receptors are disclosed. The 5-HT(2C) receptor agonists are used in the treatments of disease and conditions wherein modulation of 5-HT(2C) receptors provides a benefit, such as obesity and psychiatric disorders.
    Type: Grant
    Filed: February 3, 2011
    Date of Patent: July 23, 2013
    Assignees: The Board of Trustees of the University of Illinois, The University of North Carolina at Chapel Hikll
    Inventors: Alan Kozikowski, Bryan Roth, Andreas Svennebring, Sung Jin Cho